事業提携・ライセンシング・投資・M&A動向:May 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, May 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, May 2013 9
2.2.1 Valeant Pharma to Acquire Bausch & Lomb for US$8.7 Billion 9
2.2.2 Actavis to Acquire Warner Chilcott for US$8.5 Billion 10
2.2.3 Royalty Pharma Increases Its Offer Price to Acquire Elan 10
2.2.4 Merck Completes Public Offering of Notes for $6.5 Billion 11
2.2.5 Pfizer Completes Public Offering of Notes for US$4 Billion 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, May 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, May 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, May 2013 14
3.1.1 Top M&A Deals in May 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, December 2012–May 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, May 2013 17
3.2.1 Top Equity Offering Deals in May 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, December 2012–May 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, May 2013 20
3.3.1 Top PE/VC Deals in May 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, May 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, May 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, December 2012–May 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, December 2012–May 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, December 2012–May 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), May 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, May 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2012–May 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, December 2012–May 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), December 2012–May 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), December 2012–May 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), May 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, May 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, May 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, May 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), December 2012–May 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), December 2012–May 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), December 2012–May 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), December 2012–May 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, May 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, May 2013 46
6.2.1 Central Nervous System – Deals of the Month 47
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, May 2013 48
6.3.1 Infectious Diseases – Deals of the Month 49
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, May 2013 50
6.4.1 Cardiovascular – Deal of the Month 51
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, May 2013 52
6.5.1 Metabolic Disorders – Deal of the Month 53
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, May 2013 54
6.6.1 Immunology – Deal of the Month 55
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, May 2013 56
6.7.1 Respiratory – Deal of the Month 57
7 Deal Summary by Geography 58
7.1 Pharmaceuticals & Healthcare, North America Deals, May 2013 58
7.1.1 North America – Deals of the Month 59
7.2 Pharmaceuticals & Healthcare, Europe, Deals, May 2013 60
7.2.1 Europe – Deals of the Month 61
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, May 2013 62
7.3.1 Asia-Pacific – Deals of the Month 63
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, May 2013 64
7.4.1 Rest of the World – Deals of the Month 65
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 66
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, December 2012–May 2013 66
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, December 2012–May 2013 67
9 Further Information 68
9.1 Methodology 68
9.2 About GlobalData 69
9.3 Contact Us 69
9.4 Disclosure information 69
9.5 Disclaimer 69


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:May 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals
■ 発行日:2013年6月7日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161118
■ 調査対象地域:グローバル
  • 自動車タイヤの世界市場2015-2025
    Visiongain’s new report calculates that the world market for automotive tires will reach $198.78bn in 2015 and the market is a dynamic and fast changing business. The automotive tires market can broadly be divided into two divisions -original equipment tires fitted by the vehicle manufacturer at the factory and the replacement aftermarket. Tires fitted as original equipment naturally follow the gl …
  • 世界の腎臓結石管理装置市場動向(2014-2018)
    About Kidney Stones Management Devices Kidney stones are mineral and acid salts such as calcium crystals that are formed in the kidneys. The formation of stones in the kidneys is known as urolithiasis, which is one of the most common urological disorders worldwide. It causes obstruction to the drainage of urine from the kidneys and often causes severe pain. Kidney stone management devices help to …
  • 好酸球性食道炎(Eosinophilic Esophagitis):世界の治験レビュー(2015年上半期版)
    Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H1, 2015" provides data on the Eosinophilic Esophagitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Eosinophilic Esophagitis. It includes an overview of the trial num …
  • 世界の商用航空機市場動向2013-2023:トレンド、開発動向及び課題
    Technological Developments in the global Commercial Aircraft include: ■ Renewed focus on developing technologies to maximize fuel efficiency ■ Research and development efforts oriented towards reduction in noise pollution ■ Improved turbulence detection systems to prevent crashes ■ Fast growth in emerging markets ■ Growing demand for fuel efficient aircraft ■ Regional jets to experience greater de …
  • Noble Energy, Inc.:石油・ガスバリューチェーン分析レポート2013
    Noble Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Noble Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Noble Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
  • Fairfield Energy Ltd:石油・ガスの開発・生産動向及びコスト分析- 2012
    Fairfield Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Fairfield Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
  • 潤滑剤の世界市場予測:ベース油別、製品種類別、用途別
    “Global lubricants market projected to grow at a CAGR of 2.7% during the forecast period.”The global lubricants market size is projected to reach USD 188.0 billion by 2024 from USD 164.3 billion in 2019, at a CAGR of 2.7%. The growth is primarily due to the massive development in Asia Pacific and the Middle East & Africa, coupled with the rise in the Industrial sector. The factors restraining the …
  • Baytex Energy Corp.:石油・ガスバリューチェーン分析レポート2013
    Baytex Energy Corp. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Baytex Energy Corp." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Baytex Energy Corp.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
  • 世界のTV/ビデオデリバリープラットフォーム(データベース)
    As on-demand video consumption develops, traditional TV distribution is being challenged more and more by the various paths for delivering video products over IP. On a worldwide basis, fixed digital networks (digital cable & IPTV) are expected to enjoy a greater increase of the TV access supply market than digital broadcast TV, with a CAGR of 14.7% between 2009 and 2018, compared to 9.2% for broad …
  • 医療用バイオバンキング市場(2014-2024)
    Biobanks - how to find business trends, R&D, and revenue forecasts What does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data, helping your authority. There you explore developmental trends, sales results, opportunities, and revenue forecasts. That new report by visiongain shows you what's possible for biobanking and a …
  • トリグリセリド(中性脂肪)の市場別医療検査数および販売予測
    This new report from Venture Planning Group provides analysis of Triglycerides testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing   - Hospitals - Commercial/Private Laboratori …
  • 性器ヘルペス(Genital Herpes):世界の治験レビュー(2015年上半期版)
    Genital Herpes Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2015" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries co …
  • 消毒薬の世界市場2017-2021
    About Sanitizer Alcohol-based sanitizers contain at least 70% alcohol, mainly ethyl alcohol, which tend to kill 99.9% of the bacteria on hand after application within 30 seconds, and 99.99% to 99.999% within a minute. Alcohol kills both pathogenic microorganisms as well as resident bacterial flora, thus avoiding illness. Research shows that alcohol hand sanitizers do not eliminate good microorgani …
  • 海洋テレマティクスの世界市場:コンポーネント別、用途別
    Telematics is the methodology used to monitor the location and movement of a ship through a hardware and software assembly. It also has a combination of Global Positioning System (GPS) and on-board diagnostics systems. With the help of GPS and diagnostics system, it is possible to record the speed and internal behavior of a ship. Telematics systems are mainly adopted by automobile insurance compan …
  • 特発性肺動脈高血圧(Idiopathic Pulmonary Hypertension):治療薬のグローバル治験動向(2014年下半期)
    Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Idiopathic Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic Pulmonary Hypertension. It i …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。